Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rancho Research Institute, Inc. | OTHER |
Not provided
Not provided
Not provided
This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental: FitMi AD Exercise Program | Experimental | Participants will perform exercises by interacting with FitMi pucks, as described and monitored on a tablet computer. Participants will be asked to exercise at least 30 minutes per day for 3 months. |
|
| Active Comparator: Conventional booklet of exercise program | Active Comparator | Participants will perform exercises described in a booklet similar to what is typically provided to individuals. Participants will be asked to exercise at least 30 minutes per day for 3 months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| FitMi AD | Device | Exercise using the motion sensing devices and a tablet computer |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Functional Reach Test | How far can someone reach while standing in a fixed position | Baseline, Immediately Post-Treatment (an average of 3 months) |
| Change in Timed Up and Go test | Time it takes to stand up from a chair and walk a short distance | Baseline, Immediately Post-Treatment (an average of 3 months) |
| Change in 30 second chair stand test | How many times someone stand up from a chair in 30 seconds | Baseline, Immediately Post-Treatment (an average of 3 months) |
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analog Pain Scale | Indicates perceived pain intensity. The scale consists of a line, often 10 cm long, with verbal anchors at either end (i.e. "no pain" on the far left and "the most intense pain imaginable" on the far right). The patient places a mark at a point on the line corresponding to the patient's rating of pain intensity. | Baseline, Immediately Post-Treatment (an average of 3 months) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Freddi Segal-Gidan, PA, PhD | Rancho Research Institute, Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rancho Research Institute, Inc | Downey | California | 90242 | United States |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jun 20, 2026 |
| ID | Term |
|---|---|
| D060825 | Cognitive Dysfunction |
| D003704 | Dementia |
| D008224 | Lymphoma, Follicular |
| ID | Term |
|---|---|
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D001927 | Brain Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Single (Outcomes Assessor)
| Conventional exercise program | Other | Exercise following printed sheets or booklet |
|
| Global Physical Activity Questionnaire | Assesses physical activity habits | Baseline, Immediately Post-Treatment (an average of 3 months) |
| Geriatric Depression Scale | Evaluates depression in elderly individuals. Scores of 0-4 are considered normal, depending on age, education, and complaints; 5-8 indicate mild depression; 9-11 indicate moderate depression; and 12-15 indicate severe depression. | Baseline, Immediately Post-Treatment (an average of 3 months) |
| Pittsburgh Sleep Quality Index | Measures the quality and patterns of sleep in adults. Each item is weighted on a 0-3 interval scale. The global PSQI score is then calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality. | Baseline, Immediately Post-Treatment (an average of 3 months) |
| Duration of exercise performed | Duration of exercise performed over intervention period. | Immediately Post-Treatment (an average of 3 months) |
| D002493 |
| Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D008228 | Lymphoma, Non-Hodgkin |
| D008223 | Lymphoma |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |